{"id":"NCT01398410","sponsor":"Eisai Co., Ltd.","briefTitle":"Long-term Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)","officialTitle":"Long-term Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment. - A Multicenter, Randomized, Parallel-group, Open-label Trial-","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2011-12","primaryCompletion":"2013-12","completion":"2014-02","firstPosted":"2011-07-20","resultsPosted":"2015-11-16","lastUpdate":"2015-12-21"},"enrollment":405,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Gastric Ulcers Duodenal Ulcers Caused by Low-dose Aspirin"],"interventions":[{"type":"DRUG","name":"Rabeprazole","otherNames":["E3810, Pariet/Aciphex"]},{"type":"DRUG","name":"Rabeprazole","otherNames":["E3810, Pariet/Aciphex"]}],"arms":[{"label":"Rabeprazole 5 mg","type":"EXPERIMENTAL"},{"label":"Rabeprazole 10 mg","type":"EXPERIMENTAL"}],"summary":"The primary objective of this study to examine the long-term safety of rabeprazole 5 mg or 10 mg tablets administered once daily in participants who were confirmed to have no recurrence of gastric or duodenal ulcer by endoscopic examination at the end of 24 weeks of treatment in the E3810-J081-308 (NCI01397448) \\[Double-Blind Phase\\] study. From a total of 420 participants who completed the E3810-J081-308 study, 328 entered the E3810-J081-309 (NCT01398410) study.","primaryOutcome":{"measure":"Percentage of Participants With Treatment Emergent Adverse Events (AEs)","timeFrame":"For each participant, from administration of first dose of study drug (rabeprazole) up to 30 days from administration of last dose of study drug (rabeprazole) or up to 76 weeks (including data from the Double-Blind Phase)","effectByArm":[{"arm":"Rabeprazole 5 mg","deltaMin":77.1,"sd":null},{"arm":"Rabeprazole 10 mg","deltaMin":83.8,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":null},"locations":{"siteCount":50,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":33,"n":201},"commonTop":["Nasopharyngitis","Diarrhoea","Back pain","Constipation","Contusion"]}}